|
Therapeutic targeting of clonal hematopoiesis in RUNX1 mutant FPDMM |
University of Pennsylvania |
The RUNX1 Research Program |
|
Effects of standardized, prospective Epstein-Barr virus (EBV) monitoring on the natural history and outcomes of post-transplant lymphoproliferative disorder and EBV-associated smooth muscle tumor in pediatric solid organ transplantation patients |
Children’s Hospital of Philadelphia |
Northwestern Mutual Foundation |
|
Identification of phenotypic effects of genomic changes in retinoblastoma tumors using an aqueous humor liquid biopsy |
Children’s Hospital Los Angeles |
Northwestern Mutual Foundation |
|
Incidence and grades of adverse events during treatment for pediatric acute lymphoblastic leukemia |
Emory University |
Northwestern Mutual Foundation |
|
IL7 signaling enhanced CAR T cells to treat pediatric solid tumors |
Baylor College of Medicine |
Northwestern Mutual Foundation |
|
Structure-guided de novo design of molecules that selectively target EWS-FLI1 |
University of Texas Health Science Center at San Antonio |
Marshall County Childhood Cancer Awareness Corporation |
|
A Cell Morphology Landscape of Pediatric Cancer Cell Lines |
University of Colorado Denver_ Anschutz Medical Campus |
Tap Cancer Out |
|
Circumventing Pediatric Solid Tumor Microenvironment Resistance by Combinatorial CAR NK and Immunomodulating Therapy |
New York Medical College |
Sammy’s Superheroes Foundation |
|
Immunoglobulin High-Throughput Sequencing for Refining Risk Stratification in Infant B-ALL |
University of Rochester |
Cure4Cam Childhood Cancer Foundation |
|
Development of RADARS-based Therapy to Treat Fusion Molecule Driven Pediatric Malignancies |
Boston Children’s Hospital |
Jack’s Helping Hand |
